There are 410 resources available
Yes
Presenter: Egbert Smit
Session: Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?
Resources:
Slides
Webcast
Case presentation
Presenter: Fiona McDonald
Session: Place of radiotherapy in advanced SCLC treated with IO: Brain and thorax
Resources:
Slides
Webcast
What is the role of brain radiotherapy?
Presenter: Corinne Faivre-Finn
Session: Place of radiotherapy in advanced SCLC treated with IO: Brain and thorax
Resources:
Slides
Webcast
No
Presenter: Heather Wakelee
Session: Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Lizza Hendriks
Session: Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?
Resources:
Slides
Webcast
Discussion
Presenter: Fiona McDonald
Session: Place of radiotherapy in advanced SCLC treated with IO: Brain and thorax
Resources:
Slides
Webcast
1O - Osimertinib versus gefitinib followed by osimertinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE trial
Presenter: JORDI REMON MASIP
Session: Proffered Paper 1
Resources:
Abstract
Slides
Webcast
Maximizing outcomes from molecular diagnosis (Part2 - in the molecular lab)
Presenter: Fernando Lopez-Rios
Session: Updates on molecular diagnosis
Resources:
Slides
Webcast
Searching for fusions beyond ALK and ROS1
Presenter: Teodora Radonic
Session: Updates on molecular diagnosis
Resources:
Slides
Webcast
Smoking and lung cancer
Presenter: Boris Duchemann
Session: Lung cancer beyond tobacco: Impact of environmental and other risk factors
Resources:
Slides
Webcast